[18F]Fluoromethylcholine as a Chemotherapy Response Read-Out in Prostate Cancer Cells

Daniela E. Oprea‐Lager(Amsterdam University Medical Centers), Albert A. Geldof(Amsterdam UMC Location VUmc), R. Jeroen A. van Moorselaar(Amsterdam UMC Location Vrije Universiteit Amsterdam), Irene V. Bijnsdorp(Amsterdam UMC Location Vrije Universiteit Amsterdam), Alfons J.M. van den Eertwegh(Amsterdam University Medical Centers), Otto S. Hoekstra(Amsterdam Neuroscience), Peter M. van de Ven(Amsterdam UMC Location Vrije Universiteit Amsterdam), Mitchell P. van Kanten(Amsterdam UMC Location Vrije Universiteit Amsterdam)

Molecular Imaging and Biology

November 19, 2014

10.1007/s11307-014-0803-7

Cited by 11

Related Papers

Nontemplated Nucleotide Additions Distinguish the Small RNA Composition in Cells from Exosomes

|Cell Reports|2014|592

Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial

|European Urology|2018|577

A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.

|PubMed|2002|507

Urinary extracellular vesicles: A position paper by the Urine Task Force of the International Society for Extracellular Vesicles

|Journal of Extracellular Vesicles|2021|410

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

|The Lancet Oncology|2021|392